LiteOdyssey: A Lightweight Reasoning AI Agent for Interpretable Rare-Disease Diagnosis
Researchers have developed LiteOdyssey, a lightweight AI agent designed for interpretable rare-disease diagnosis. This framework guides a reasoning language model through a clinical genetics workflow, utilizing human-AI collaboration and publicly available biomedical tools. LiteOdyssey achieved state-of-the-art performance on two challenging benchmarks, demonstrating high disease recall without requiring extensive fine-tuning, multi-agent ensembles, or large retrieval databases. AI
IMPACT Demonstrates a novel approach to rare-disease diagnosis using lightweight AI agents, potentially improving accessibility and transparency in medical AI.